{"id":"W4283808736","doi":"10.7326/m22-1300","title":"Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial","year":2022,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Placebo; 2019-20 coronavirus outbreak; Double blinded; Randomized controlled trial; Clinical trial; Virology; Antibody; Antibody response; Immunology; Internal medicine; Pathology; Outbreak; Infectious disease (medical specialty); Alternative medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004371812,0.001958088,0.003050522,0.0003133753,0.0007843792,0.001056054,0.0007449602,0.002416881,0.006928959],"category_scores_gemma":[0.004170906,0.0007134954,0.001869114,0.0002821121,0.00115389,0.001085092,0.0005489683,0.001961935,0.001208231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008597948,"about_ca_system_score_gemma":0.002240245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009802758,"about_ca_topic_score_gemma":0.001869181,"domain_scores_codex":[0.9976655,0.001265692,0.0001958695,0.0003842733,0.0001566907,0.0003320743],"domain_scores_gemma":[0.9979705,0.0004703637,0.0006243647,0.0002182672,0.0002546023,0.0004619165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9910682,0.002792253,0.0004960061,0.0002146335,0.0002629817,0.00001486226,0.00003074431,0.00007470194,0.001100325,0.00004253547,0.000491745,0.00341108],"study_design_scores_gemma":[0.9414148,0.05524436,0.001889208,0.00003497611,0.0002399932,0.00001361404,0.00001021684,0.0001573905,0.0003721732,0.0001132932,0.000501857,0.000008194246],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678143,0.002880815,0.001115736,0.0006893792,0.0009754671,0.02048416,0.002204539,0.000168003,0.00366755],"genre_scores_gemma":[0.9697022,0.0008601065,0.002124239,0.0008458985,0.0005484068,0.02212912,0.001460114,0.00002254856,0.002307338],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006928959,"threshold_uncertainty_score":0.02317965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1579958370817668,"score_gpt":0.4924747767857831,"score_spread":0.3344789397040163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}